267 related articles for article (PubMed ID: 19368692)
1. H-cadherin expression reduces invasion of malignant melanoma.
Kuphal S; Martyn AC; Pedley J; Crowther LM; Bonazzi VF; Parsons PG; Bosserhoff AK; Hayward NK; Boyle GM
Pigment Cell Melanoma Res; 2009 Jun; 22(3):296-306. PubMed ID: 19368692
[TBL] [Abstract][Full Text] [Related]
2. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma.
Kuphal S; Bosserhoff AK
Oncogene; 2006 Jan; 25(2):248-59. PubMed ID: 16132038
[TBL] [Abstract][Full Text] [Related]
3. Functional implication of truncated P-cadherin expression in malignant melanoma.
Bauer R; Bosserhoff AK
Exp Mol Pathol; 2006 Dec; 81(3):224-30. PubMed ID: 16919267
[TBL] [Abstract][Full Text] [Related]
4. A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma.
Chen X; Lin J; Kanekura T; Su J; Lin W; Xie H; Wu Y; Li J; Chen M; Chang J
Cancer Res; 2006 Dec; 66(23):11323-30. PubMed ID: 17145878
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
[TBL] [Abstract][Full Text] [Related]
6. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
7. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.
Kudo Y; Kitajima S; Ogawa I; Hiraoka M; Sargolzaei S; Keikhaee MR; Sato S; Miyauchi M; Takata T
Clin Cancer Res; 2004 Aug; 10(16):5455-63. PubMed ID: 15328184
[TBL] [Abstract][Full Text] [Related]
8. P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma.
Van Marck V; Stove C; Van Den Bossche K; Stove V; Paredes J; Vander Haeghen Y; Bracke M
Cancer Res; 2005 Oct; 65(19):8774-83. PubMed ID: 16204047
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development.
Li G; Schaider H; Satyamoorthy K; Hanakawa Y; Hashimoto K; Herlyn M
Oncogene; 2001 Dec; 20(56):8125-35. PubMed ID: 11781826
[TBL] [Abstract][Full Text] [Related]
10. A secreted form of P-cadherin is expressed in malignant melanoma.
Bauer R; Hein R; Bosserhoff AK
Exp Cell Res; 2005 May; 305(2):418-26. PubMed ID: 15817166
[TBL] [Abstract][Full Text] [Related]
11. Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration.
Winklmeier A; Contreras-Shannon V; Arndt S; Melle C; Bosserhoff AK
Cancer Sci; 2009 Feb; 100(2):261-8. PubMed ID: 19200257
[TBL] [Abstract][Full Text] [Related]
12. Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling.
Li G; Fukunaga M; Herlyn M
Exp Cell Res; 2004 Jul; 297(1):142-51. PubMed ID: 15194432
[TBL] [Abstract][Full Text] [Related]
13. The role of cadherin/catenin complex in malignant melanoma.
Bonitsis N; Batistatou A; Karantima S; Charalabopoulos K
Exp Oncol; 2006 Sep; 28(3):187-93. PubMed ID: 17080010
[TBL] [Abstract][Full Text] [Related]
14. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
[TBL] [Abstract][Full Text] [Related]
15. P-cadherin expression reduces melanoma growth, invasion, and responsiveness to growth factors in nude mice.
Jacobs K; Feys L; Vanhoecke B; Van Marck V; Bracke M
Eur J Cancer Prev; 2011 May; 20(3):207-16. PubMed ID: 21445019
[TBL] [Abstract][Full Text] [Related]
16. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.
Rodriguez M; Aladowicz E; Lanfrancone L; Goding CR
Cancer Res; 2008 Oct; 68(19):7872-81. PubMed ID: 18829543
[TBL] [Abstract][Full Text] [Related]
17. Expression of Hugl-1 is strongly reduced in malignant melanoma.
Kuphal S; Wallner S; Schimanski CC; Bataille F; Hofer P; Strand S; Strand D; Bosserhoff AK
Oncogene; 2006 Jan; 25(1):103-10. PubMed ID: 16170365
[TBL] [Abstract][Full Text] [Related]
18. Involvement of cadherins 7 and 20 in mouse embryogenesis and melanocyte transformation.
Moore R; Champeval D; Denat L; Tan SS; Faure F; Julien-Grille S; Larue L
Oncogene; 2004 Sep; 23(40):6726-35. PubMed ID: 15273735
[TBL] [Abstract][Full Text] [Related]
19. Cadherin expression in melanocytic naevi and malignant melanomas.
Cowley GP; Smith ME
J Pathol; 1996 Jun; 179(2):183-7. PubMed ID: 8758211
[TBL] [Abstract][Full Text] [Related]
20. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
